vs
Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and DDC Enterprise Ltd (DDC). Click either name above to swap in a different company.
BIOHARVEST SCIENCES INC. is the larger business by last-quarter revenue ($8.4M vs $5.4M, roughly 1.6× DDC Enterprise Ltd).
BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.
BHST vs DDC — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.4M | $5.4M |
| Net Profit | — | $-6.7M |
| Gross Margin | 60.3% | 31.4% |
| Operating Margin | — | -90.0% |
| Net Margin | — | -123.3% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $5.4M | ||
| Q3 25 | $8.4M | — | ||
| Q2 25 | $8.1M | $2.2M | ||
| Q1 25 | $7.7M | — | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $6.0M | — |
| Q4 25 | — | $-6.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $715.3K | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | 31.4% | ||
| Q3 25 | 60.3% | — | ||
| Q2 25 | 60.0% | 33.4% | ||
| Q1 25 | 58.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | -90.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | -123.3% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 33.2% | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $21.7M |
| Total DebtLower is stronger | — | $610.8K |
| Stockholders' EquityBook value | — | $71.2M |
| Total Assets | — | $199.6M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $21.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $3.5M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | $610.8K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | $71.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | $199.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $12.4M | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-39.7M |
| Free Cash FlowOCF − Capex | — | $-39.7M |
| FCF MarginFCF / Revenue | — | -734.1% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-39.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | $-39.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | -734.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
